» Articles » PMID: 8405710

Quantification of the Relationship Between Insulin Sensitivity and Beta-cell Function in Human Subjects. Evidence for a Hyperbolic Function

Overview
Journal Diabetes
Specialty Endocrinology
Date 1993 Nov 1
PMID 8405710
Citations 466
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the relationship between insulin sensitivity and beta-cell function, we quantified the insulin sensitivity index using the minimal model in 93 relatively young, apparently healthy human subjects of varying degrees of obesity (55 male, 38 female; 18-44 yr of age; body mass index 19.5-52.2 kg/m2) and with fasting glucose levels < 6.4 mM. SI was compared with measures of body adiposity and beta-cell function. Although lean individuals showed a wide range of SI, body mass index and SI were related in a curvilinear manner (P < 0.0001) so that on average, an increase in body mass index was associated generally with a lower value for SI. The relationship between the SI and the beta-cell measures was more clearly curvilinear and reciprocal for fasting insulin (P < 0.0001), first-phase insulin response (AIRglucose; P < 0.0001), glucose potentiation slope (n = 56; P < 0.005), and beta-cell secretory capacity (AIRmax; n = 43; P < 0.0001). The curvilinear relationship between SI and the beta-cell measures could not be distinguished from a hyperbola, i.e., SI x beta-cell function = constant. This hyperbolic relationship described the data significantly better than a linear function (P < 0.05). The nature of this relationship is consistent with a regulated feedback loop control system such that for any difference in SI, a proportionate reciprocal difference occurs in insulin levels and responses in subjects with similar carbohydrate tolerance. We conclude that in human subjects with normal glucose tolerance and varying degrees of obesity, beta-cell function varies quantitatively with differences in insulin sensitivity.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

High-Intensity Interval Training for Individuals With Isolated Impaired Fasting Glucose: Protocol for a Proof-of-Concept Randomized Controlled Trial.

Thirunavukkarasu S, Ziegler T, Weber M, Staimez L, Lobelo F, Millard-Stafford M JMIR Res Protoc. 2025; 14:e59842.

PMID: 39977858 PMC: 11888011. DOI: 10.2196/59842.


Hypomagnesemia, insulin secretion and action in patients without diabetes, 1 year after kidney transplantation.

Carlsen R, Asberg A, Svensson M, Birkeland K, Jorgensen H, Bressendorff I Front Med (Lausanne). 2025; 12:1492871.

PMID: 39911868 PMC: 11797832. DOI: 10.3389/fmed.2025.1492871.


Exploring the potential role of C-peptide in type 2 diabetes management.

Lin Y, McCrimmon R, Pearson E Diabet Med. 2025; 42(3):e15469.

PMID: 39797595 PMC: 11823364. DOI: 10.1111/dme.15469.


Insulin secretion, sensitivity, and clearance in normoglycemic Black and White adults with parental type 2 diabetes: association with incident dysglycemia.

Edeoga C, Asuzu P, Wan J, Dagogo-Jack S BMJ Open Diabetes Res Care. 2024; 12(6.

PMID: 39719314 PMC: 11683886. DOI: 10.1136/bmjdrc-2024-004545.


Exploring the effects of ime-restricted ating on body weight and associated cardiometabolic outcomes in outh frican women living with HIV (TESSA): protocol for a randomised controlled trial.

Mendham A, Goedecke J, Heckens L, Hoosen F, Pico M, Kengne A BMJ Open. 2024; 14(12):e086203.

PMID: 39627134 PMC: 11624751. DOI: 10.1136/bmjopen-2024-086203.